Explorez tous les épisodes du podcast ATTD: Advanced Technologies and Treatments for Diabetes

In this episode of ATTD Diabetes Talks: The Power of Weekly Insulin, host Diana Isaacs joins Dr. Alice Cheng to discuss practical strategies for starting and titrating weekly insulin in routine clinical practice.

Key Discussion Points:

• Initiating weekly insulin therapy in routine clinical practice

• Key considerations when determining the starting dose

• How titration differs from daily basal insulin regimens

• Recommended monitoring approaches during the initiation phase

• Common challenges in early treatment and real-world strategies to overcome them

Guest: Dr. Alice Cheng (Professor at the University of Toronto; Endocrinologist at Trillium Health Partners and St. Michael’s Hospital)

You can find more resources on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

This series is supported by Eli Lilly & Company.

In this episode of ATTD Diabetes Talks, host Diana Isaacs is joined by Dr. Medha Munshi, Director of the Joslin Geriatric Diabetes Program and Professor of Medicine at Harvard Medical School. Together, they discuss the science behind weekly insulin, patient selection criteria, tailoring therapy to individual needs, and specific considerations for older or medically complex adults.

Key Takeaways:

• Criteria & Patient Characteristics for Weekly Insulin

• Managing Resistance, Comorbidities & Lifestyle

• Benefits for Older Adults & Complex Patients

• Individualizing Treatment & Best Practices

  
  

You can find more resources on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

This series is supported by Eli Lilly & Company.

In this episode, we explore the science behind weekly insulin, including the pharmacology of weekly insulin, its mechanism of action, how it differs from daily insulin formulations, and why it provides consistent control over a longer period.

Guest: Dr. Manasi Shah, Assistant Professor of Medicine at Eastern Virginia Medical School and Director of the Inpatient Diabetes Program at Sentara Norfolk General Hospital

Key discussion points:

• What are the key pharmacokinetic properties that enable once-weekly insulin administration?

• How does the pharmacodynamic profile differ from that of daily basal insulin formulations?

• What mechanisms allow weekly insulin to provide sustained glucose control over several days?

• How does this prolonged action translate into clinical glycemic stability?

• What are the key pharmacological considerations clinicians should be aware of when interpreting data on weekly insulin?

• What remaining scientific questions need to be addressed before broader clinical adoption?

You can find more resources on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

This series is supported by Eli Lilly & Company

In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin, we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management.

Guest: Dr. Rodolfo Galindo (Associate Professor of Medicine and Director of the Comprehensive Diabetes Center at the University of Miami Health System)

Key Topics Covered:

• The Evolution of Basal Insulin: A look back at the progression from early long-acting formulations to current weekly treatment options.

• Pharmacological Innovation: Understanding the science that makes weekly insulin formulations possible.

• Clinical Advantages: Exploring the theoretical benefits of weekly versus daily basal insulin.

• Patient Impact: Examining how shifting to a weekly regimen affects treatment burden and overall patient experience.

• Future Outlook: How weekly insulin is poised to fit into the broader landscape of diabetes care.

Resources:

• For more in-depth knowledge and exclusive content, visit the ATTD Education Portal.

Subscribe to the podcast to stay updated on the latest in diabetes management.

Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populations

In this final episode, we dive into:

• Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy, including injection fatigue and tech-retention issues for active youth.

• The INHALE-1 Study: A deep dive into the randomized controlled trial data of 230 youth, highlighting efficacy, per-protocol non-inferiority, less weight gain, and superior treatment satisfaction among kids and parents.

• Safety Profile: Analyzing forced expiratory volume (FEV1) data showing an excellent safety signal with no differences in pulmonary function or severe hypoglycemic events.

• Practical Toolkit Use Cases: How the unique pharmacokinetic profile of inhaled insulin provides unmatched benefits for covering adrenaline-rush highs and avoiding hypoglycemia tail effects during sports and exercise.

• Dosing Guidelines: Overcoming the practical "paradigm shift" of converting injected units to inhaled units and managing dosing effectively.

• Future Horizons: Anticipating the "INHALE FIRST" study investigating early onboarding for newly diagnosed patients and introducing a new two-unit inhaled insulin cartridge.

About ATTD Diabetes Talks:

A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation.

Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/

Subscribe to the podcast for more updates on advancing diabetes care.

#DiabetesManagement #PediatricEndocrinology #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Type1Diabetes

Chapters:

00:00 Intro and Unique Challenges in Pediatric Diabetes Management

02:38 The INHALE-1 Study: Efficacy, Satisfaction, and Weight Findings

06:27 Safety Signals, Pulmonary Function, and Adherence Challenges

10:18 Practical Toolkit Use Cases: Managing Sports and Exercise

12:48 Dosing Conversions and Practical Patient Selection Guidelines

15:02 Off-Label Integration with Automated Insulin Delivery (AID) Systems

20:14 Caregiver & School Nurse Roles and Managing Safety Concerns

22:00 Research Gaps, The INHALE FIRST Trial, and Wrap Up

Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems.

In this episode, we dive into:

• The potential of combining inhaled insulin with current AID technologies.

• Theoretical advantages, including postprandial management.

• Current evidence, clinical considerations, and existing evidence gaps.

• Practical insights for clinicians on patient education and system integration.

About ATTD Diabetes Talks:

A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation.

Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/

Subscribe to the podcast for more updates on advancing diabetes care.

#DiabetesManagement #AIDSystems #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Endocrinology

Chapters:

00:00 Intro

03:03 How Inhaled Insulin Works

07:30 Real World Dosing Workflow

10:24 Exercise and Safety Upside

15:45 Clinician Education Tips

17:38 Research Gaps and Trials Needed

19:32 Future Potential and Wrap Up

In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation.

Key discussion points:

• Defining therapeutic inertia in the context of insulin initiation.

• Common clinician and patient-related barriers that contribute to treatment delays.

• Practical strategies for introducing inhaled insulin to hesitant patients.

• System-level considerations, including workflow and reimbursement challenges.

Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/

Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together.

#DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcast

Chapters:

00:00 Why Inhaled Insulin Matters

00:34 Show Intro and Guest

01:22 Defining Therapeutic Inertia

02:19 Clinician Barriers to Insulin

03:49 Patient Fears and Hesitation

05:28 How Inhaled Insulin Helps

07:00 Best Fit Patient Scenarios

08:22 Talking to Hesitant Patients

10:39 Workflow and Coverage Hurdles

13:35 PFT Testing and Side Effects

14:47 Future Role and Wrap Up

In our new series, The Role of Inhaled Insulin, host Dr David Ahn looks at the practical implementation of inhaled insulin in clinical practice. He is joined by Dr Irl Hirsch.

They discuss:

• Where inhaled insulin fits today within the overall insulin therapy landscape

• The best candidates for inhaled insulin in routine clinical practice

• Key clinical factors to guide decision-making

• Practical first steps to initiating inhaled insulin

• Approaches to titration

• Monitoring strategies, particularly regarding pulmonary safety and glycemic outcomes

• Shared decision-making and engaging patients

Dr Irl Hirsch is Professor of Medicine, in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington School of Medicine. 

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy.

They discuss:

• The most common mistakes or misconceptions in basal insulin initiation and management

• Intensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinations

• Leveraging technologies to improve insulin adherence and outcomes

• Managing hypoglycemia concerns and achieving glycemic targets

• Addressing psychological and behavioral barriers to insulin use in everyday clinical practice

Dr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations.

They discuss:

• Why personalization is particularly important in insulin therapy

• The patient groups most in need of a tailored approach

• How comorbidities or frailty influence insulin decision-making

• Guidelines, flexibility, and local solutions

Dr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients.

They discuss:

• The barriers most misunderstood by clinicians

• Communication and motivational interviewing with patients

• Emotional burden and fear of hypoglycemia

• Practical strategies clinicians can use to support patients more effectively

• The role of the wider diabetes healthcare team

Diana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education.

They discuss:

• Why hypoglycemia remains a major concern in insulin therapy

• Key risk factors to keep in mind

• Clinical signs or patient-reported symptoms

• Prevention strategies

• Importance of patient education

• Balancing glycemic targets with hypoglycemia risk

Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support.

They discuss:

• The new technologies making the biggest difference in insulin therapy today

• The role of smart pens, connected devices, and apps

• Biggest clinical impact - including adherence, titration and outcomes

• Accessibility of these tools in real-world practice

• Advisor role of AI

• The promising future of technology in insulin therapy and a functional cure

Professor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations.

They discuss:

• What exactly fixed-ratio combinations are and the problems they tackle

• Identifying patient candidates and timelines for starting FRCs

• Meaningful benefits of FRCs compared with basal insulin alone

• Concerns and limitations of FRCs

• How guideline recommendations currently position FRCs in diabetes management

Dr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.

They discuss:

• The importance of titration in successful insulin therapy

• Barriers to titration, including patient self-management

• How clinicians can collaborate with patients in their titration journey

• The importance of language used by clinicians

• Practical tips for simplifying titration in busy clinical settings

Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes.

They discuss:

• When clinicians should consider insulin for patients with T2D

• Addressing concerns of weight gain with insulin

• ADA/EASD recommendations

• Barriers to insulin therapy and Type 2 diabetes

• Advice on communication with patients

Dr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use.

He is joined by Dr Giulio Romeo.

They discuss:

• The role of basal insulin in normal physiology and why it matters in Type 2 diabetes

• Goals of basal insulin therapy

• What makes new basal insulins different

• Current guidelines and recommendations for basal insulin therapy

• Alternatives to basal insulin therapy

• Tips for safe and effective initiation and titration

Dr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo 

• Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia 

• C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu 

This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz 

• Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey 

• Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri 

• Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca 

This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess 

• CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews 

• Non-invasive Glucose Monitoring – Dr. Lutz Heinemann 

• CGM Use in Clinical Trials – Prof. Pratik Choudhary 

This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. 

While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel 

• Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell 

• Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard 

• Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch 

This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 

https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Refining Care of Type 1 Diabetes – Dr. Lori Laffel 

• Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly 

• Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs 

• Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck 

This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Managing Overweight & Obesity in Type 1 Diabetes, featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes. 

As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman 

• Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown 

• Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally 

This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 

https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Adjunct Therapies with Automated Insulin Delivery, featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes. 

As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 diabetes-such as SGLT-2 inhibitors and GLP-1 receptor agonists-may complement automated insulin delivery systems to optimize glycemic control and potentially improve cardiometabolic outcomes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• ADJUST T1D Study – Design and Glycemic Outcome – Dr. Viral N. Shah (United States of America) presents the study design and early glycemic outcomes of the ADJUST T1D trial, evaluating the impact of adjunct therapies alongside automated insulin delivery. 

• ADJUST T1D Study – Cardiovascular Outcomes – Dr. Janet K. Snell-Bergeon 

• Concurrent Use of AID with SGLT-2 – Dr. Ahmad Haidar

• Real-Life Data on GLP Use in Type 1 Diabetes – Associate Professor Francisco J. Pasquel 

This episode is an essential listen for endocrinologists, diabetologists, clinical researchers, and healthcare professionals involved in diabetes technology looking to understand emerging strategies that combine automated insulin delivery with adjunct pharmacological therapies to enhance diabetes management. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 

https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Continuous and Intermittent Glucose Monitoring – Professor Jennifer Sherr (United States of America)

• Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal (United States of America)

• New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester (Germany)

• Closed-Loop, Decision Support, and Artificial Intelligence – Dr. Mark Clements (United States of America) examines advances in automated insulin delivery systems and AI-supported diabetes management. 

• Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman highlights the expanding role of digital tools in diabetes prevention and care. 

• Technology and Pregnancy – Jennifer M. Yamamoto (Canada) reviews the use of diabetes technologies to support glucose management during pregnancy. 

• Diabetes Technology and Therapy in the Pediatric Age Group – Prof. David M. Maahs (United States of America) discusses technological and therapeutic advances in pediatric diabetes care. 

• Advances in Exercise and Nutrition as Therapy in Diabetes – Prof. Michael C. Riddell (Canada) explores the evolving role of lifestyle interventions supported by technology. 

• Primary Care and Diabetes Technologies and Treatments – Dr. Gregg D. Simonson (United States of America) examines how innovations in diabetes care are being integrated into primary care settings. 

• Use of Technologies at the Advanced Age – Dr. Anna Kahkoska (United States of America) discusses the challenges and opportunities of implementing diabetes technologies in older adults. 

• The Real “Real World”: Overcoming Practical Barriers and Disparities in Diabetes Technology – Dr. Ananta Addala (United States of America) highlights real-world challenges in access and implementation. 

• Diabetes Technology in the Hospital – Tim Hropot (Slovenia) reviews the role of diabetes technologies in inpatient care. 

• Impact of Diabetes Technologies on Psychosocial Outcomes – Alon Liberman (Israel) discusses how technological advances affect quality of life and psychosocial wellbeing. 

• Immune Intervention and Beta Cell Replacement Therapies in Type 1 Diabetes – Prof. Desmond Schatz (United States of America) reviews emerging therapeutic approaches aimed at modifying disease progression. 

• Obesity and Diabetes – Dr. Viral N. Shah (United States of America) examines the evolving relationship between obesity and diabetes management. 

• Emerging Trends in MASLD and MASH – Prof. Satish K. Garg (USA) explores new insights into metabolic liver disease and its links to diabetes. 

• Virtual Clinics for Diabetes Care – Prof. Satish K. Garg discusses the growing role of telemedicine and virtual care models. 

• New Medications for the Treatment of Diabetes – Prof. Satish K. Garg reviews emerging pharmacological therapies shaping the future of diabetes treatment. 

This episode is an essential listen for endocrinologists, diabetologists, researchers, and healthcare professionals in diabetes care looking to stay up to date with the most important technological, therapeutic, and clinical developments presented at ATTD 2026. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 
https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Debate: HbA1c and Not CGM Should Be the Gold Standard to Evaluate Glucose Control, featuring a dynamic exchange of perspectives on the most accurate method for assessing glucose control in diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Pro – Dr. Elizabeth Selvin 

• Con – Dr. Richard M. Bergenstal 

• Moderator – Dr. Irl B. Hirsch 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking insights into the ongoing debate between HbA1c and Continuous Glucose Monitoring (CGM) in evaluating glucose control. Gain a deeper understanding of the arguments for and against each method, and the implications for diabetes management. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into What Else Is New? Featuring the latest advancements in the treatment and monitoring of Type 1 diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Adjunctive Treatment with GLP/GIPS for Patients with Type 1 Diabetes: Consensus Report and Guidelines for Safer Use – Prof. Satish Garg 

• An International Consensus on Screening and Monitoring Early-stage Type 1 Diabetes: A Roadmap to European Implementation – Online First Release – Dr. Sufyan Hussain 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the newest consensus guidelines and the future of screening and treatment strategies for Type 1 diabetes. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into The Use of Technology in Treating Type 2 Diabetes, featuring cutting-edge insights into how technological advancements are transforming diabetes management. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Using Apps to Support Management of Type 2 Diabetes — Prof. Julia Mader 

• Connected Pens in Type 2 Diabetes — Prof. Concetta Irace 

• CGM in Type 2 Diabetes — Dr. J. Hans DeVries 

• Automated Insulin Delivery in Type 2 Diabetes — Prof. Yves Reznik 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking to stay ahead of the curve on the integration of technology into Type 2 diabetes treatment. Get the latest on how apps, connected devices, CGM, and automated insulin delivery systems are shaping modern care. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Real Life Use of Continuous Glucose Monitoring (CGM), featuring an in-depth exploration of CGM's expanding role in diabetes management across various patient populations. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• CGM Frequency Use in Type 2 Diabetes — Prof. Satish Garg 

• CGM for Prediabetes — Dr. Viral N Shah 

• CGM in Individuals Without Diabetes — Dr. Smadar Shilo 

• Adapting CGM Reports for The Use in Real Life — Dr. Richard M. Bergenstal 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the latest CGM applications, offering insights into real-world utilization, practical reporting, and implications for a broader range of patients. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Scientific Parallel Session 01: Screening and Treatment Options for Delaying Onset of Type 1 Diabetes, featuring the latest research and clinical perspectives on early detection, risk stratification, and preventive interventions in Type 1 diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Screening Programs for Type 1 Diabetes in the US: From Research to Standard of Care – Prof. Michael J. Haller (United States of America) 

• Could CGM Replace Antibodies Screening? – Prof. Boris Kovatchev, PhD (USA) 

• Is It Time to Re-Evaluate Our Recommendations for Screening the General Population for Risk for Type 1 Diabetes? – Prof. Desmond Schatz, MD (United States of America) 

• Cost Effectiveness of Screening and Immune Interventions in Type 1 – Prof. Shweta Mital (Canada) 

This episode is an essential listen for endocrinologists, diabetologists, pediatric specialists, and diabetes researchers looking to better understand the evolving landscape of Type 1 diabetes screening strategies and preventive therapies. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 
https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Transforming Diabetes Management with Artificial Intelligence (AI), featuring cutting-edge research on how AI-driven technologies are reshaping personalized diabetes care and automated insulin delivery. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Combining Digital Twins and LLMs for Advanced Personalized Insulin Therapy in Type 1 Diabetes – Dr. Giacomo Cappon 

• A Week of Automated Insulin Delivery Used to Titrate Basal Insulin in Type 2 Diabetes – Dr. Heman Shakeri 

• Fully Automated Closed-Loop Based on Artificial Intelligence – Prof. Marc D. Breton 

This episode is an essential listen for clinicians, endocrinologists, diabetes researchers, and digital health professionals looking to understand the evolving role of artificial intelligence in optimizing insulin therapy and automated diabetes care. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Hot from the Oven, featuring the latest advancements in diabetes care and treatments. Join us as we summarize key takeaways from these thought-provoking presentations: 

• Evaluation of CGM-based Insulin Dose Guidance System in People with Type 1 and Type 2 Diabetes: Single Arm Feasibility Study - Prof. Andrej Janež 
• FREEDM2 RCT: New Insights into CGM with Basal Insulin in T2DM - Dr. Emma G. Wilmot 
• Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults Initiating Treatment Early in the Course of Type 2 Diabetes: Results from SURPASS-Early Study after 2 Years of Treatment - Prof. Stefano Del Prato 
• The Progress Study: Phase 1/2 Clinical Trial of KRIYA-839, a Novel AAV Gene Therapy for Adults with Type 1 Diabetes - Dr. Jeremy Pettus 

This episode is an essential listen for healthcare professionals in endocrinology and diabetes care, looking to stay up-to-date with cutting-edge research and treatment advancements. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. attd.kenes.com 

We’re excited to launch the ATTD 2026 Conference Catch-Up, a brand-new, AI-powered podcast designed for healthcare professionals who want to stay ahead in diabetes care. 

Whether you’re attending ATTD 2026 in Barcelona or following from afar, this podcast ensures you don’t miss a thing. Using AI-driven podcast generation, we’ll bring you key takeaways from select sessions, breaking down the latest in screening and treatment of T1D, CGM, new technologies, AI use, weight management in diabetes, and more. 

Get ready for insightful summaries! 

ATTD 2026 is taking place on 11-14 March, in Barcelona, Spain. It's the ultimate conference to discover the latest worldwide research, devices, therapies and developments in the diabetes field. 

Find out more: https://attd.kenes.com/ 

In this episode of ATTD Tech Connect, host Julie Taplin and Dr Anna Korsgaard Berg discuss skin care management for people living with diabetes using diabetes technology.

They discuss:

• The different skin layers and how they can be impacted by the use of diabetes technology

• How poor skin integrity directly affects glucose outcomes

• Things to look out for and ask as a clinician

• Some practical prevention strategies

• Latest research on using ultrasounds to measure skin depth

Dr Anna Korsgaard Berg is a Diabetes researcher at Steno Diabetes Center, Copenhagen and works in Pediatrics at Herlev Hospital.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professor Katarzyna Cyranka, clinical psychologist and psychotherapist, discuss the important topic of burden and quality of life related to diabetes and diabetes technologies for people living with diabetes.

They discuss:

• Distinguishing diabetes distress from diabetes burnout

• Possible sources of diabetes distress

• The role of diabetes technology, especially AHCL, in reducing diabetes distress

• Signs to watch out for as clinicians, nurses, and educators

• Tools to assist in naming and identifying sources of diabetes distress

Professor Katarzyna Cyranka is a clinical psychologist and certified psychotherapist, based in Krakow, Poland. 

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professors Tadej Battelino and Klemen Dovč discuss the importance of multi-disciplinary diabetes care, and offer solutions to the common challenges that can crop up when managing a diabetes team.

They discuss:

• Common challenges such as time constraints, busy clinics, and comorbidities

• Solutions such as effective communication, regular meetings, and the use of AI in automating workloads

• Importance of synergy across various departments and professions within diabetes care

Professor Tadej Battelino is Co-Chair of ATTD and Chair of the International Diabetes Federation Europe. Professor Klemen Dovč is an Associate professor in the Faculty of Medicine at the University of Ljubljana.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Amy Jolley, Lead Diabetes Specialist Dietician, discuss exercise management in diabetes and the ways the MiniMed™ 780G system supports people with diabetes and healthcare professionals.

They discuss:

• Barriers to exercise for people living with diabetes

• The different glucose responses to aerobic and anaerobic exercise 

• The features and benefits of AID systems compared with MDI therapy 

• Advice on bolusing, fuelling during exercise, pre and post meal suggestions and ways to help reduce hypos

Amy Jolley is a Lead Diabetes Specialist Dietician for the young adult and transition services at Salford Care Organisation, NHS, in the UK.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Ashley Mehnert, Diabetes Clinical Nurse Specialist, break down the Smart MDI system and its benefits.

They discuss:

• What exactly is Smart MDI system

• How it differentiates from standard MDI therapy

• Benefits, including visibility to insulin use

• The actionable alerts and clinical impact

Ashley Mehnert is a Diabetes Clinical Nurse Specialist working in the NHS in the north east of England.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Maya Laron Hirsh, Clinical Dietician, discuss managing meals with the MiniMed™ 780G system.

They discuss:

• Carb counting

• What to do if you miss a bolus

• How to handle high fat and/or protein meals

Maya Laron Hirsh is a Clinical Dietician, Head of Diabetes & Obesity Nutrition Department at Sheba Medical Center, and Chair of the Diabetes Forum, Israeli Dietetic Association. She specializes in nutritional therapy for automated insulin delivery systems and has worked closely with people with diabetes using the 780G system.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guests explore how healthcare professionals can make the most of CareLink™ Clinic - a powerful tool for supporting healthcare professionals and people living with Type 1 diabetes.

They discuss:

• An overview of the CareLink™ Clinic reports

• The three-Step Methodology for Healthcare Professionals

• Using CareLink™ Clinic reports for Patient Education

• Dietary Insights and CareLink™ Clinic 

Douha Almajaly is a Diabetes Educator, and Maheen Ahmed is a Clinical Dietician, both from Sidra Medicine. Professor Goran Petrovski is the Medical Director for Medtronic Diabetes and an Endocrinologist & Diabetologist working at Sidra Medicine.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

How can diabetes educators be supported in the fast-moving world of diabetes technology?

In the first episode of ATTD Tech Connect, host Julie Taplin discusses the need for an educational pathway for diabetes educators when training PwD on the MiniMed™ 780G system with Geraldine Gallen.

They discuss:

• Why the pathway is needed

• The four key components of the pathway

• The barriers to providing diabetes educator training

• Implementing the pathway at King’s College Hospital

Geraldine Gallen is a Type 1 Service Lead and Diabetes Nurse Consultant at Kings College Hospital, London. She is UK​ and Vice Chair of the Association of British Clinical Diabetologists (ABCD) – Diabetes Technology Network (DTN), UK​. 

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• Minimed Medtronic Academy and WePartner Online

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Diabetes technology is evolving fast. In ATTD Tech Connect, we show how it can help healthcare professionals — nurses, educators, and dieticians — improve therapy and daily life for people living with diabetes.

In this new series sponsored by Medtronic Diabetes, you’ll learn from diverse clinical experience and evidence-based guidance from leaders in diabetes care, tailored for those who support patients every day.

Hosted by Julie Taplin, Dietician and Medtronic Diabetes Education Specialist, the series will explore practical strategies to reduce burden, support meal planning and exercise, and optimize outcomes in real-world care.

Make sure you’re subscribed to the ATTD Podcast feed today.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
• Minimed Medtronic Academy and WePartner Online

In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek.

They discuss:

• High-Risk Pregnancies and Current Gaps in Care

• Challenges in Type 2 Diabetes Research

• Impact of CGM Technology During Pregnancy

• Pre-Pregnancy and Pregnancy Care for Type 2 Diabetes

• Third Trimester and Delivery Considerations

• Early Adoption of Hybrid Closed Loops

Dr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event.

She is joined by Dr Grenye O’Malley.

They discuss:

• How glucose patterns and insulin needs change postpartum

• GDM as a spectrum to Type 2 diabetes

• CGM use for early detection of type 2 diabetes after GDM

• Strategies for transitioning from intensive pregnancy care to postpartum follow-up

Grenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.

They discuss:

• Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatigue
• Practical troubleshooting strategies for clinicians and patients

• The role of education and support in overcoming CGM-related challenges

Sarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is the Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.

She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.

They discuss:

• How CGM improves maternal and neonatal outcomes

• Key clinical trials including the CONCEPTT trial

• Evolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)

Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.

They discuss:

• How AI and CGM technology is transforming diabetes and metabolic health management

• AI identification of diabetes subtypes and personalised interventions

• Impact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellness

• Potential of AI-driven tools for early intervention and improved health outcomes

Dr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.

To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.

They cover:

• The Role of AI in Continuous Glucose Monitoring

• Challenges and Potential of AI in Diabetes Management

• AI and CGM for Young People with Diabetes

• Potential for AI to instigate behaviour change

Dr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.

They explore a wide range of topics including:

• General challenges in managing diabetes
• Adjusting insulin doses for better control
• Time in tight range (TITR) and insulin management
• Fasting and diabetes management
• Impact of GLP-1 on Type 1 diabetes management
• Challenges of switching to weekly insulin injections
• Defining and managing hypoglycemia risk
• Personalized diabetes management approaches
• Diabetes management in athletes

Dr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.

They cover:

• Challenges and solutions in real-world insulin therapy

• How personalized strategies improve patient outcomes

• Lessons learned from patient-provider collaborations

• Future opportunities for enhancing patient engagement and adherence

• How to balance diabetes care with lifestyle choices

Christel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.

Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.